The annual meeting of the American Academy of Neurology was held from April 2 to 7 in Seattle and attracted more than 38,000 participants from around the world, including clinicians, academicians, allied health professionals, and others interested in neurology. The conference highlighted recent advances in neurological disorders, with presentations focusing on the diagnosis, management, and […]
SEATTLE — A decrease in the severity of tics in children and adolescents with Tourette syndrome was observed following the use of ecopipam, according to data presented at the 2022 American Academy of Neurology annual meeting.
“Our results are exciting, because they suggest ecopipam shows promise as a treatment for reducing the number, frequency and severity of the tics young people
/PRNewswire/ According to a new preliminary study, children and teens with Tourette syndrome who are treated with an experimental drug called ecopipam may.
Ecopipam, an investigational medicine, may improve tic severity scores in children and adolescents with Tourette syndrome three months after treatment,